Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT02077166 · COMPLETED
Trial details
- NCT number
- NCT02077166
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-13
- Primary completion
- 2020-12-17
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.